Premium
Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy
Author(s) -
Irimada Moyuka,
Fujimura Taku,
Kambayashi Yumi,
Tsukada Akira,
Takahashi Toshiya,
Hashimoto Akira,
Aiba Setsuya
Publication year - 2019
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.14778
Subject(s) - dabrafenib , medicine , trametinib , internship , dermatology , medical education , melanoma , vemurafenib , cancer research , mapk/erk pathway , kinase , metastatic melanoma , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom